Genpact Buy Hold or Sell Recommendation

G -- USA Stock  

0.085 Dividend

Taking into account the 30 trading days horizon, and your above average risk tolerance our recommendation regarding Genpact Limited is 'Strong Hold'. Macroaxis provides Genpact buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Genpact positions. The advice algorithm takes into account all of Genpact Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Genpact buy-and-hold prospective. Please also check Genpact Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell GenpactBuy Genpact
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Genpact Limited has a risk adjusted performance of (0.002343), jensen alpha of (0.08), total risk alpha of (0.16), sortino ratio of 0.0 and treynor ratio of (0.031134)
Genpact Limited buy, hold, or sell recommendation module can be used to check and cross-verify current buy or sell recommendations provided by analysts evaluating the entity potential to grow using all of fundamental, technical, data market data available at the time. To make sure Genpact Limited is not overpriced, please check out all Genpact fundamentals including its EBITDA, Current Ratio and the relationship between Price to Sales and Cash per Share . Given that Genpact Limited has Price to Earning of 26.32 , we strongly advise you confirm Genpact Limited market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Genpact Trading Alerts and Improvement Suggestions

Genpact Limited generates negative expected return over the last 30 days
Genpact Limited has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its interest payments
About 62.0% of the company shares are owned by institutional investors
Latest headline from Trade Alert The Independent Director Of Genpact Limited , Carol Lindstrom, Has Sold Some Shares Recently - Simply Wall St

Genpact current analysts recommendations

Target Median Price47.00
Target Mean Price46.27
Recommendation Mean1.90
Target High Price48.00
Number Of Analyst Opinions11
Target Low Price44.00

Genpact Returns Distribution Density

Mean Return0.02Value At Risk2.45
Potential Upside1.49Standard Deviation1.24
 Return Density 

Genpact Greeks

Alpha over DOW
Beta against DOW=0.80
Overall volatility
Information ratio =0.07

Genpact Volatility Alert

Genpact Limited exhibits very low volatility with skewness of -0.83 and kurtosis of 0.23. However, we advise investors to further study Genpact Limited technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Genpact to competition

Genpact Fundamental Vs Peers

FundamentalsGenpactPeer Average
Return On Equity0.17 (0.31) 
Return On Asset0.09 (0.14) 
Profit Margin0.10 (1.27) 
Operating Margin15.97 (5.51) 
Current Valuation8.68 B16.62 B
Shares Outstanding190.5 M571.82 M
Shares Owned by Insiders0.61 10.09 
Shares Owned by Institutions62.19 39.21 
Number of Shares Shorted1.43 M4.71 M
Price to Earning26.32 28.72 
Price to Book4.69 9.51 
Price to Sales2.27 11.42 
Revenue3.27 B9.43 B
Gross Profit1.08 B27.38 B
EBITDA518.98 M3.9 B
Net Income287.31 M570.98 M
Cash and Equivalents379.8 M2.7 B
Cash per Share1.99 5.01 
Total Debt1.64 B5.32 B
Debt to Equity103.80 48.70 
Current Ratio1.46 2.16 
Book Value Per Share5.88 1.93 K
Cash Flow from Operations129.92 M971.22 M
Short Ratio1.31 4.00 
Earnings Per Share1.48 3.12 
Price to Earnings To Growth1.60 4.89 
Number of Employees93 K18.84 K
Market Capitalization7.42 B19.03 B
Total Asset2.79 B29.47 B
Retained Earnings313.52 M9.33 B
Working Capital600.59 M1.48 B
Current Asset1.2 B9.34 B
   Sale by Carol Lindstrom of 5000 shares of Genpact [view details]